STOCKS TELEGRAPH

Tag: Aurora Cannabis Inc.

  • Aurora Cannabis (ACB) Rides High On Germany’s Cannabis Act

    Aurora Cannabis (ACB) Rides High On Germany’s Cannabis Act

    Aurora Cannabis Inc. (NASDAQ: ACB) is seeing a significant increase in trading value of 22.30%, with a most recent check of $5.27. The recent passing of the German Cannabis Act and the current increase in the price of ACB’s shares on the US stock exchange are related.

    With the formal implementation of the Cannabis Act, Aurora Cannabis (ACB) has accepted the German government’s final approval of cannabis legalization, which represents a major step forward in enhancing patient access to medicinal cannabis.

    This legislative modification is a long-overdue reform intended to promote greater accessibility to the medicinal cannabis industry and show a strong dedication to patients. It establishes a standard for international growth attempts and is consistent with the progressive policies of leading nations like Canada.

    Aurora Cannabis has always supported a more liberal approach to cannabis, and Germany’s reform initiatives have significantly improved patient access to medicinal marijuana. Aurora Cannabis, a leader in the industry, has consistently upheld patient welfare.

    It will strengthen Aurora Cannabis’ commitment to patient outreach and ensure widespread access to premium medical cannabis since cannabis is no longer considered a narcotic, which will enable more patients to get treatment. By improving accessibility, Aurora Cannabis demonstrates its commitment to promoting positive change in the cannabis industry.

    Aurora Cannabis, one of the country’s top suppliers of medicinal cannabis, can fortify its stronghold on the market with these developments, along with the cultural significance of cannabis legalization in Germany.

    Cannabis’s reclassification as a non-narcotic drug is expected to encourage more patients to discuss its medicinal benefits with their doctors, creating more access, understanding, and knowledge of its benefits.

    Parallel to this, Aurora Cannabis recently received approval for its Canadian manufacturing facilities, River and Ridge, under the Good Manufacturing Practices (GMP) program from the Therapeutic Goods Administration (TGA) of Australia. The TGA is in charge of overseeing the manufacture, distribution, import, export, and promotion of medicinal products inside Australia.

  • Aurora Cannabis Inc. (ACB) stock Bullish Amid Potential Federal Legalization Vote

    Aurora Cannabis Inc. (ACB) stock Bullish Amid Potential Federal Legalization Vote

    On March 24, Aurora Cannabis Inc. (ACB) stock along with many other cannabis stocks traded in the green upon potential federal legalization vote. The latest news from the company itself was on March 23, regarding the acquisition of TerraFarma Inc.

    Source: Merriam-Webster

    ACB stock increased by 10.99% during the regular session followed by a gain of 18.56% in the after-hours. The stock had a value of $4.04 per share at the close of regular trading, while it reached up to $4.79 in the after-hours session. The volume of the day remained above the average with 21.55 million shares exchanging in the regular session and 3.48 million in the after hours.

    The cannabis products producer, Aurora Cannabis Inc. is based in Canada and was founded in 2006. Currently, the company’s 214.77 million outstanding shares trade at a market capitalization of $783.39 million. Standing on a year-to-date loss of 25.32%, ACB stock has added 16.09% in the past five days. Moreover, the stock subtracted a value of 56.42% in the past year.

    Potential Federal Legalization Vote

    On March 24, Yahoo Finance Live reported a potential federal legalization vote of marijuana by the US House of Representatives. According to the report, the US House of Representatives has officially included Marijuana Opportunity Reinvestment and Expungement (MORE) Act in the list of bills to be taken up on the House floor next week. The MORE Act was previously taken up by the House floor in December 2020. Thus, with the possibility of its federal legalization vote marijuana stocks including ACB were trending actively on Thursday.

    ACB’s TerraFarma Acquisition

    On March 22, the company announced its agreement for the acquisition of all the issued and outstanding shares of TerraFarma Inc. TerraFarma is the parent company of Thrive Cannabis. And, Thrive is a licensed producer of super-premium cannabis concentrates and craft dried flowers.

    The transaction consideration includes $38 million in cash and ACB common shares along with two earnout amounts (in ACB share or cash). Furthermore, the earnout consideration is based on the achievement of certain revenue targets by Thrive within two years.

    Additionally, the transaction is expected to close in the fourth quarter of 2022 as per ACB’s fiscal year. Also, the company expects to achieve positive adjusted EBITDA in H1 2023 due to the transaction.

    ACB’s Fiscal Q2 2022

    In fiscal Q2 2022 ended on December 31, 2021, ACB’s net revenue was $60.6 million with an adjusted EBITDA loss of $9.0 million.

    Also, the company ended the quarter with $383.8 million of cash along with $51.3 million in restricted cash.

  • Aurora Cannabis Inc. (ACB) Stock Plunging in Aftermarket, Here’s the Reason.

    Aurora Cannabis Inc. (ACB) is a leading global cannabis provider to the industry, as it serves the medical and consumer markets. Its adult-use portfolio includes Aurora Drift, Daily Special, San Rafael ’71 along with certain CBD brands. The company’s medical portfolio includes CanniMed, MedReleaf, and Whistler Medical Marijuana Co.

    The price of ACB stock during the regular trading on February 10, 2022, was $4.59 with a 1.08% drop. At last check in the aftermarket, the stock was further down by 4.58%.

    ACB: Key Financials

    On February 10, 2022, ACB released its financial results for the second fiscal quarter of 2022 ended December 2021. Some of the major highlights are discussed below.

    Revenue

    Total net revenue in the second quarter of 2022 was C$60.5 million versus C$67.6 million in the same period of 2021. Total revenue decreased in the yearly period by C$7.08 million or 10%.

    EPS

    Basic and diluted net loss per share in Q2 2022 was C$75.1 million or $0.38 compared to C$297.9 million or $1.77 in the same period of 2021.

    ACB: Events and Happenings

    On February 3, 2022, ACB’s subsidiary Relive reported about the launch of KG7. It is a high-quality CBD portfolio prepared according to the needs of adult consumers with an active lifestyle. On January 4, 2022, ACB updated about delivering the cannabis shipment worth C$10 million to Israel.

    On December 14, 2021, ACB along with 22nd Century Group, Inc. informed about a three-way non-exclusive contract to license biosynthesis intellectual property to Cronos Group Inc. The intention of the contract is to contribute in the research and development advancement of cannabinoid biosynthesis.

    On December 13, 2021, ACB was acknowledged by The Globe and Mail’s 2021 annual Report on Business review of Corporate Boards. The company received 77/100 eligible points, positioned notably higher than other cannabis companies.

    Conclusion

    ACB underplayed by 68% in the previous year as economic conditions were in an appalling state due to pandemics. The recent aftermarket stock decline is because the company didn’t meet its expectations in the second quarter of 2022. The revenue in the year-ago period was more than its current-quarter revenue.

  • 23 stocks making the biggest moves in the premarket today

    23 stocks making the biggest moves in the premarket today

    DPW Holdings Inc. (DPW) stock soared 2.5% to $7.37 in the pre-market trading after the company revealed that its power electronics business, Coolisys Technologies Corp., has established a program targeting both national and regional fast-food franchises to install the ACECool™ electric vehicle (“EV”) chargers as a part of a revenue sharing program.

    Naked Brand Group Limited (NASDAQ: NAKD) shares are trading up 9.19% at $0.2008 at the time of writing. Company’s 52-week ranged between $0.07 to $4.00.

    Ideanomics Inc. (IDEX) grew over 15.27% at $3.02 in pre-market trading today. The firm reported that it has increased its stake in California-based Solectrac, Inc. through a follow-on investment of an additional $1.3 million.

    Sundial Growers Inc. (SNDL), a Drug Manufacturers – Specialty & Generic company, rose about 72.38% at $0.4151 in pre-market trading Tuesday. The company recently publicized that it will participate in Cowen’s 2020 Boston Cannabis Conference, to be held virtually between November 30 and December 2, 2020.

    Li Auto Inc. (NASDAQ: LI) shares are trading up 6.99% at $46.69 at the time of writing. Company’s 52-week ranged between $14.31 to $40.81. Analysts have a consensus price target of $45.60.

    Tantech Holdings Ltd (TANH) grew over 23.36% at $2.64 in pre-market trading today following the firm declared that it has entered into a securities purchase agreement with institutional investors to purchase approximately $10 million of its common shares and registered warrants to purchase common shares in a registered direct offering as well as unregistered warrants to purchase common shares in a concurrent private placement.

    Marathon Patent Group Inc. (MARA), a Capital Markets company, rose about 16.26% at $5.72 in pre-market trading Tuesday.

    Ayro Inc. (AYRO) lost over -5.75% at $9.99 in pre-market trading Tuesday November 24, 2020 after the firm revealed that it has entered into definitive agreements with Carnegie Hudson Resources, an investment arm of Wanxiang America, and several existing institutional investors.

    Carnival Corporation & Plc (CCL) is up more than 6.49% at $19.36 in pre-market hours Tuesday November 24, 2020 after the recent declaration that the company has closed its previously announced registered direct offering of 10.4 million shares of its common stock at a price of $17.59 per share to a holder of its 5.75% Convertible Senior Notes due 2023.  The stock had jumped over 4.66% to $18.18 in the last trading session.

    Before the trading started on November 24, 2020, Occidental Petroleum Corporation (OXY) is up 7.42% to reach $16.93. It has been trading in a 52-week range of $8.52 to $47.58.

    Fuel Tech Inc. (FTEK) stock soared 57.45% to $4.44 in the pre-market trading. The most recent rating by H.C. Wainwright, on March 13, 2020, is a Neutral.

    Kandi Technologies Group Inc. (NASDAQ: KNDI) shares are trading up 8.17% at $16.15 at the time of writing as the firm publicized that it closed the registered direct offering of 8,849,560 units (the “Units”) of its securities at a purchase price per Unit of $11.30 on November 23, 2020, as previously announced on November 20, 2020. Company’s 52-week ranged between $2.17 to $17.40.

    Tilray Inc. (TLRY) grew over 19.31% at $7.97 in pre-market trading today after company’s publication that it has entered into a privately negotiated exchange agreement with a certain holder of its 5.00% Convertible Senior Notes due 2023.

    Barrick Gold Corporation (GOLD), a Gold company, dropped about -2.67% at $22.62 in pre-market trading Tuesday after Loncor Resources provided an update on its exploration activities within the Ngayu greenstone belt, where the Company has a joint venture with Barrick Gold (DRC) Limited as well as its own majority-owned projects.

    Switchback Energy Acquisition Corporation (SBE) grew over 20.04% at $40.91 in pre-market trading today.

    iBio Inc. (IBIO), a Biotechnology company, dropped about -3.4% at $1.42 in pre-market trading Tuesday. The healthcare company recently reported that the United States Patent and Trademark Office has issued U.S. Patent No. 10,844,392, entitled “Materials and Methods for Producing Endostatin Fusion Polypeptides in Plant Cells,” which, amongst other claims, covers a novel expression cassette that enhances the yield of endostatin fragments and variants using iBio’s FastPharming® System.

    Ferroglobe PLC (GSM) stock moved down -13.67 percent to $1.2 in the pre-market trading after the firm declared results for the third quarter of 2020.

    Longview Acquisition Corp. (LGVW) stock soared 24.26% to $16.9 in the pre-market trading.

    Ocean Power Technologies Inc. (NASDAQ: OPTT) shares are trading up 43.32% at $3.11 at the time of writing after the firm proclaimed that Jorge Franco has joined the Company as Regional Sales Representative based in Spain. Reporting to OPT Vice President, Global Sales Jeff Wiener, Mr. Franco will concentrate on opportunities in Southern Europe. Company’s 52-week ranged between $0.33 to $3.72.

    Kosmos Energy Ltd. (KOS) grew over 8.95% at $2.07 in pre-market trading today.

    Before the trading started on November 24, 2020, Ballard Power Systems Inc. (BLDP) is down -3.75% to reach $20.77 following announcement of US$250 million bought deal offering of common shares by the company. It has been trading in a 52-week range of $5.50 to $21.61.

    Bloom Energy Corporation (BE) stock soared 8.61% to $23.98 in the pre-market trading. The most recent rating by Raymond James, on February 20, 2020, is a Mkt perform.

    Energous Corporation (WATT) stock soared 9.13% to $2.51 in the pre-market trading. The most recent rating by Ladenburg Thalmann, on May 01, 2019, is a Buy.

    Canaan Inc. (NASDAQ: CAN) shares are trading up 7.31% at $5.43 at the time of writing. The technology company recently told that it will release its third-quarter 2020 financial results before the market opens on Monday, November 30, 2020. The company’s 52-week ranged between $1.76 to $13.00.

  • Top 15 Healthcare Stocks You Should Add To Your Bucket

    The global generics drug market continues to grow with the increasing demand for more medication. Drug manufacturers are continuously striving to meet the need for more generic drugs. This industry is an opportunity-rich industry. Efficient and inexpensive drugs are often needed. The drug manufacturing industry has seen a huge transformation over the last two decades.

    This industry-main challenge is to provide the drug at lower prices than branded drugs. Drug manufacturers and Specialty Generic Industry will face more pressure in the coming years to lower the prices of drugs.  The industry is expected to grow significantly over the next decade. Check out the leading companies in drug manufacturers- specialty generic industry to see how these are addressing the needs of their customers:

    Sundial Growers Inc. (NASDAQ: SNDL)

    Sundial Growers Inc. (NASDAQ: SNDL) shares were trading down -6.32% at $0.17 at the time of writing on Wednesday. Sundial Growers Inc. (NASDAQ: SNDL) share price went from a low point around $0.17 to briefly over $4.12 in the past 52 weeks, though shares have since pulled back to $0.17. SNDL market cap has remained high, hitting $32.59M at the time of writing, giving it a price-to-sales ratio of more than 0.

    Sundial Growers Inc. (SNDL) has revealed earlier that it has expanded the Palmetto brand presence across Canada. If we look at the recent analyst rating SNDL, CIBC upgraded coverage on SNDL shares with a Neutral rating.

    Teligent Inc. (NASDAQ: TLGT)

    Teligent Inc. (NASDAQ: TLGT) last closed at $1.04, in a 52-week range of $0.65 to $8.00. The Schall Law Firm has earlier revealed that it is investigating claims on behalf of investors in Teligent, Inc. for potential breaches of fiduciary duty on the part of its directors and management. Teligent Inc.’s market cap has remained high, hitting $5.68 Million at the time of writing.

    Zomedica Corp. (AMEX: ZOM)

    Zomedica Corp. (AMEX: ZOM) stock drop by -3.82% to $0.08. Zomedica Corp. (ZOM) revealed that it has changed its legal name to Zomedica Corp. The Company’s stock trading symbol will remain as ZOM on the NYSE American and the shares will start trading under the new name effective on October 5, 2020.

    Aurora Cannabis Inc. (NYSE: ACB)

    Aurora Cannabis Inc. (NYSE: ACB) shares headed rising, higher as much as 6.36%. The most recent rating by Jefferies, on September 21, 2020, is at a Hold. Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of Aurora Cannabis Inc. (ACB) shareholders.

    Tilray Inc. (NASDAQ: TLRY)

    Tilray Inc. (NASDAQ: TLRY) rose 2.96% after gaining more than $0.19 on Wednesday. Tilray Inc. (TLRY) earlier revealed that its wholly-owned subsidiary, High Park Holdings Ltd. has introduced the newest addition to its cannabis-infused edible product line: Chowie Wowie Gummies, which are now available in select provinces across Canada.

    Neos Therapeutics Inc. (NASDAQ: NEOS)

    Neos Therapeutics Inc. (NASDAQ: NEOS) last closed at $0.86, in a 52-week range of $0.45 to $1.98. Neos Therapeutics Inc. (NEOS) has reported that its sales in quarter two reached $13.13 million. However, earnings dropped by 51.17%, resulting in a loss of $2.88 million. In Q1, Neos Therapeutics brought in $14.49 million in sales but lost $5.89 million in earnings.

    Teva Pharmaceutical Industries Limited (NYSE: TEVA)

    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares headed rising, higher as much as 3.72%. The most recent rating by Barclays, on August 06, 2020, is at an Equal-weight. Pomerantz LLP revealed that a class action lawsuit has been lodged against Teva Pharmaceuticals Industries Limited and certain of its officers.

    Elanco Animal Health Incorporated (NYSE: ELAN)

    Elanco Animal Health Incorporated (NYSE: ELAN) shares headed falling, lower as much as -2.56%. The most recent rating by Morgan Stanley, on August 20, 2020, is at an Overweight. Elanco Animal Health Incorporated (ELAN) has revealed that it has got a notification of an unsolicited ‘mini-tender”‘ offer by TRC Capital Investment Corporation to buy up to 4,000,000 shares of Elanco common stock, representing approximately 1.00% of the outstanding shares of Elanco common stock.

    HEXO Corp. (NYSE: HEXO)

    HEXO Corp. (NYSE: HEXO) fall -0.91% after losing more than -$0.01 on Wednesday. HEXO Corp. (HEXO) has earlier disclosed that it has appointed Trent MacDonald to its executive leadership team in the acting role of Chief Financial Officer, effective October 10, 2020. Its market cap has remained high, hitting $365.78 million at the time of writing.

    Bausch Health Companies Inc. (NYSE: BHC)

    Bausch Health Companies Inc. (BHC) last closed at $17.57, in a 52-week range of $11.15 to $31.97. Analysts have a consensus price target of $26.76. Bausch Health Companies Inc. (BHC) and Lomb, its leading global eye health business, along with BHVI, revealed previously that an affiliate of Bausch Health has bought an exclusive license for a myopia control contact lens design developed by BHVI.

    Endo International plc (NASDAQ: ENDP)

    Endo International plc (NASDAQ: ENDP) stock drop by -5.69% to $5.47. The most recent rating by Goldman, on July 27, 2020, is at a Sell. Endo International plc (ENDP) revealed that it has decided to buy all of the outstanding shares of BioSpecifics Technologies Corp. for $88.50 in cash per share or an estimated enterprise value of approximately $540 million at the expected time of deal closure.

    China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)

    China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) stock soar by 9.65% to $0.31. China SXT Pharmaceuticals Inc. (SXTC) share has fluctuated between the 52-weeks low of $0.22 and 52-weeks high of $1.56 during the trading session of Wednesday. It has moved up 40.64% from its 52-weeks low and moved down -79.97% from its 52-weeks high.

    Canopy Growth Corporation (NYSE: CGC)

    Canopy Growth Corporation (NYSE: CGC) rose 3.23% after gaining more than $0.61 on Wednesday. Canopy Growth Corporation (CGC) share price went from a low point around $9.00 to briefly over $25.97 in the past 52 weeks, though shares have since pulled back to $19.49. CGC market cap has remained high, hitting $7.24 billion at the time of writing.

    Aphria Inc. (NASDAQ: APHA)

    Aphria Inc. (NASDAQ: APHA) last closed at $4.68, in a 52-week range of $1.95 to $6.44. Aphria Inc. (APHA) has moved up 140.00% from its 52-weeks low and moved down -27.33% from its 52-weeks high. Its market cap has remained high, hitting $1.25 billion at the time of writing.

    China Pharma Holdings Inc. (CPHI)

    China Pharma Holdings Inc. (CPHI) stock soar by 6.86% to $0.50. The most recent rating by Rodman & Renshaw, on January 08, 2010, is at an Mkt outperform. China Pharma Holdings Inc. (CPHI) has moved up 134.13% from its 52-weeks low and moved down -64.53% from its 52-weeks high. Its market cap has remained high, hitting $22.72 million at the time of writing.

  • Here’s 15 Trending Stocks In Healthcare Industry To Watch

    Here’s 15 Trending Stocks In Healthcare Industry To Watch

    The global drug manufacturers specialty & generic industry continues to grow with the increase in the demand for medication. Efficient and inexpensive drugs are the main priority of customers. Drug manufacturing is more progressive with the advent of new technologies than other areas of the pharmaceutical industry. Companies are busy in acquisitions, collaborations to increase the specialty generic capacities.

    The development of cost-effective drugs and specialty generics is a complex process.  The drug generic market has seen a huge transformation over the last few decades. Its main competitive edge is the lower prices than branded drugs. The generic industry has experienced various changes as the coronavirus pandemic takes over the world. The purchase behaviors of customers also change in 2020.

    There are various companies which are fulfilling the needs of customers in the generic industry. Here are the top 15 best players in Drug manufacturers Specialty and Generic Industry:

    Zomedica Pharmaceuticals Corp. (AMEX: ZOM)

    Zomedica Pharmaceuticals Corp. (AMEX: ZOM) shares were trading down -2.18% at $0.11 at the time of writing on Friday. Zomedica Pharmaceuticals Corp. (AMEX: ZOM) share price went from a low point around $0.10 to briefly over $0.50 in past 52 weeks, though shares have since pulled back to $0.11.

    Zomedica Pharmaceuticals Corp. (ZOM) is scheduled to present at H.C. Wainwright Virtual Global Investment Conference on September 14, 2020. Zomedica has earlier partnered with Qorvo Biotechnologies to develop three new assays Cobalamin, Canine Pancreatic Lipase, and Folate to target the diagnosis of canine gastrointestinal issues. ZOM market cap has remained high, hitting $62.09M at the time of writing.

    Teva Pharmaceutical Industries Limited (NYSE: TEVA)

    Teva Pharmaceutical Industries Limited (NYSE: TEVA) last closed at $8.79, in a 52-week range of $6.25 to $13.76. Analysts have a consensus price target of $12.19. Teva Pharmaceutical Industries Limited (TEVA) affiliate Teva Neuroscience, Inc. earlier disclosed that new study data on AUSTEDO will be presented at the International Parkinson and Movement Disorder Society annual congress (MDS Virtual Congress 2020) and during the Psych Congress 2020 Virtual Experience. Teva market cap has remained high, hitting $9.79 billion at the time of writing.

    Mylan N.V. (NASDAQ: MYL)

    Mylan N.V. (NASDAQ:; MYL) stock soar by 1.79% to $15.33. The most recent rating by SVB Leerink, on January 27, 2020, is at an Mkt perform. Mylan N.V. (MYL) has earlier bought Aspen Pharmacare Holdings Limited’s thrombosis business in Europe for €641.9 million. Mylan will pay the upfront payment of €263.2 million to Aspen. After generating cash from existing operations it will pay the €378.7 million on June 25, 2021. It has a market capitalization of $7.79 billion at the time of writing.

    Aurora Cannabis Inc. (NYSE: ACB)

    Aurora Cannabis Inc. (NYSE: ACB) last closed at $6.98, in a 52-week range of $5.30 to $78.00. Aurora Cannabis Inc. (ACB) has earlier appointed Miguel Martin its chief executive officer and also disclosed that it would book up to C$1.8 billion ($1.37 billion) in restructuring charges. It has a total market capitalization of $785.74 million at the time of writing.

    Bausch Health Companies Inc. (NYSE: BHC)

    Bausch Health Companies Inc. (NYSE: BHC) fall -1.60% after losing more than -$0.25 on Friday. Bausch Health Companies Inc. (BHC) has earlier shared its Inaugural Activity Report which showed the efforts of the Foundation from late 2017 through June 30, 2020.  Bausch Health Companies Inc. striving to improve the lives of patients globally. It has a total market cap of $5.58 billion at the time of writing.

    Endo International plc (NASDAQ: ENDP)

    Endo International plc (NASDAQ: ENDP) last closed at $2.80, in a 52-week range of $2.08 to $7.10. Endo International plc (ENDP) has earlier participated in the Citi 15th Annual BioPharma Virtual Conference being held on September 8-10, 2020. Endo International plc market cap has remained high, hitting $629.69 million at the time of writing.

    Sundial Growers Inc. (NASDAQ: SNDL)

    Sundial Growers Inc. (NASDAQ: SNDL) Shares headed falling, lower as much as -0.50%. The most recent rating by CIBC, on August 17, 2020, is at a Neutral. Sundial Growers Inc. (NASDAQ: SNDL) is scheduled to participate in
    Alliance Global Partners’ Consumer Cannabis Conference. Zachary George, Chief Executive Officer of Sundial, will take part in one-on-one sessions on September 29, 2020.

    Cronos Group Inc. (NASDAQ: CRON)

    Cronos Group Inc. (NASDAQ: CRON) fall -1.51% after losing more than -$0.08 on Friday. Cronos Group Inc. (NASDAQ: CRON) announced that its Board of Directors has named Kurt Schmidt President and Chief Executive Officer of the Company, effective September 9, 2020.  CRON also disclosed that Mike Gorenstein has been chosen as the Executive Chairman. Mike has worked as Chairman, President, and Chief Executive Officer of Cronos Group since 2016.

    Elanco Animal Health Incorporated (NYSE: ELAN)

    Elanco Animal Health Incorporated (NYSE: ELAN) last closed at $27.08, in a 52-week range of $15.17 to $32.66. Analysts have a consensus price target of $26.43. Elanco Animal Health Incorporated (NYSE: ELAN) is scheduled to participate in the Morgan Stanley 18th Annual Global Healthcare Conference on Tuesday, September 15, 2020.  Elanco Animal Health Incorporated market cap remained high, hitting $10.86 billion at the time of writing.

    Agile Therapeutics Inc. (NASDAQ: AGRX)

    Agile Therapeutics Inc. (NASDAQ: AGRX) stock soar by 2.54% to $3.63. The most recent rating by Janney, on April 12, 2019, is at a Buy. Agile Therapeutics Inc. (AGRX) is scheduled to host a virtual investor/Analyst day on Monday, September 21, 2020. It has also introduced I’m So Done, an education and empowerment platform that encourages women to think about their current contraceptive method and decision-making journey.

    Mallinckrodt plc (NYSE: MNK)

    Mallinckrodt plc (NYSE: MNK) Shares headed falling, lower as much as -7.69%. The most recent rating by JP Morgan, on May 19, 2020, is at an Underweight. Mallinckrodt plc (MNK) share price went from a low point around $1.00 to briefly over $6.42 in the past 52 weeks, though shares have since pulled back to $1.20. Mallinckrodt plc market cap has remained high, hitting $110.00 million at the time of writing.

    HEXO Corp. (NYSE: HEXO)

    HEXO Corp. (NYSE: HEXO) fall -2.82% after losing more than -$0.02 on Friday. HEXO Corp. (HEXO) share price went from a low point around $0.35 to briefly over $4.62 in the past 52 weeks, though shares have since pulled back to $0.62. HEXO Corp. market cap has remained high, hitting $331.70 million at the time of writing

    Tilray Inc. (NASDAQ: TLRY)

    Tilray Inc. (NASDAQ: TLRY) stock drop by -5.68% to $5.31. The most recent rating by The Benchmark Company, on May 12, 2020, is at a Buy. Tilray Inc. (TLRY) stock fluctuated between the 52-weeks low range of $2.43 and a high range of $32.77. It has moved up 118.52% from its 52-weeks low and moved down -83.80% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 1.80. Its market capitalization is $716.00 million.

    Momenta Pharmaceuticals Inc. (NASDAQ: MNTA)

    Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) shares headed falling, lower as much as -0.12%. The most recent rating by Cowen, on August 03, 2020, is at an Outperform. Momenta Pharmaceuticals Inc. (MNTA)  share price went from a low point around $12.21 to briefly over $52.33 in the past 52 weeks, though shares have since pulled back to $52.08. Momenta Pharmaceuticals Inc. market cap has remained high, hitting $6.20 Billion at the time of writing

    Aphria Inc. (NASDAQ: APHA)

    Aphria Inc. (NASDAQ: APHA) stock drop by -2.81% to $4.50. The most recent rating by CIBC, on August 17, 2020, is at a Sector outperform. Aphria Inc. (APHA) stock fluctuated between the 52-weeks low range of $1.95 and a high range of $7.04. It has moved up 130.77% from its 52-weeks low and moved down -36.08% from its 52-weeks high. Its market capitalization is $1.20 Billion.